ONM-421, a pH-responsive Polymer-Drug Conjugate Nanoparticle, Delivers MMAE to Solid Tumors and Shows Antigen-Independent Antitumor Efficacy in Mice 

ON-BOARD™
Written By Brad Good
Brad Good

Brad Good has been an endorsed Squarespace Expert since the beginning and has been working on the platform since 2008. He has helped hundreds of Squarespace customers with their websites.

http://www.bradgood.net
Previous

A Polymer-Drug Conjugate Platform for Tumor Specific Drug Delivery: Advancement of a Clinically Validated Ultra pH-Sensitive Micelle Technology 
Next

Results from Part-1 of ON-5001: A Multi-center, Dose Escalation and Dose Finding Phase 1 Trial of ONM-501, a Dual-Acting STING Agonist